Ernst Pharmacia CEO Nikhil Aggarwal spoke on a number of issues related to India's Pharma Industry. Chandigarh: The Indian pharmaceutical industry is undergoing a sea-change thanks to the support of the governments at the Centre and in the states, said Nikhil Aggarwal, CEO, Panchkula-based Ernst Pharmacia, adding that by 2026, there will be a remarkable transformation in cancer treatment thanks to the ongoing research in the USA. Aggarwal who founded Ernst Pharmacia which is headquartered in Panchkula was addressing different issues related to India's pharmaceutical industry during an interaction at an industry event in Tricity. “Government of India and the state governments are promoting Indian manufacturers to produce Active Pharmaceutical Ingredients (API), this will reduce India's dependence on China and other countries for API,” said Nikhil, adding that Ernst Pharmacia is committed to providing a range of high standard pharmaceutical products at affordable prices ...